Catalyst Inks Deal To End Its 'Orphan Drug' Case
By Adam Lidgett · July 12, 2022, 6:40 PM EDT
Florida-based Catalyst Pharmaceuticals Inc. has inked a deal to settle its patent case against a rival involving a drug that treats a rare autoimmune disease, ending litigation that made its way...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login